OptiNose (OPTN) Insider Trading & Ownership $9.16 -0.03 (-0.33%) As of 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OptiNose (NASDAQ:OPTN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$261,223.65 Get OPTN Insider Trade Alerts Want to know when executives and insiders are buying or selling OptiNose stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address OPTN Insider Buying and Selling by Quarter Remove Ads OptiNose Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/18/2025Michael F Marino IIIInsiderSell246$5.61$1,380.06 3/18/2025Ramy A MahmoudCEOSell368$5.61$2,064.48 3/4/2025Paul Jr. SpenceInsiderSell1,223$5.29$6,469.67 3/4/2025Ramy A MahmoudCEOSell6,376$5.29$33,729.04 7/17/2024Anthony J KrickCAOSell456$17.10$7,797.60 7/17/2024Michael F Marino IIIInsiderSell3,293$17.10$56,310.30 7/17/2024Ramy A MahmoudCEOSell7,428$17.10$127,018.80 6/18/2024Michael F Marino IIIInsiderSell217$17.85$3,873.45 6/18/2024Ramy A MahmoudCEOSell1,265$17.85$22,580.25 (Data available from 1/1/2013 forward) OPTN Insider Trading Activity - Frequently Asked Questions Who is on OptiNose's Insider Roster? The list of insiders at OptiNose includes Anthony J Krick, Michael F Marino III, Michele Janis, Paul Jr. Spence, Peter K Miller, and Ramy A Mahmoud. Learn more on insiders at OPTN. What percentage of OptiNose stock is owned by insiders? 2.30% of OptiNose stock is owned by insiders. Learn more on OPTN's insider holdings. Which OptiNose insiders have been selling company stock? The following insiders have sold OPTN shares in the last 24 months: Anthony J Krick ($12,196.80), Michael F Marino III ($104,157.51), Paul Jr. Spence ($6,469.67), and Ramy A Mahmoud ($322,728.52). How much insider selling is happening at OptiNose? Insiders have sold a total of 29,315 OptiNose shares in the last 24 months for a total of $445,552.50 sold. OptiNose Key ExecutivesDr. Ramy A. Mahmoud M.D. (Age 59)M.P.H., CEO & Director Compensation: $1.12MMr. Michael F. Marino Esq. (Age 48)Chief Legal Officer & Corporate Secretary Compensation: $785.95k1 recent tradesMr. Paul Spence (Age 55)Chief Commercial Officer Compensation: $664.02k1 recent tradesMr. Anthony J. Krick (Age 43)VP of Finance & Chief Accounting Officer Mr. Jonathan NeelyVice President of Investor Relations & Business DevelopmentMs. Karen E. Brophy (Age 61)Chief Human Resources Officer & VP of Human Resources More Insider Trading Tools from MarketBeat Related Companies Relay Therapeutics Insider Trades Rapport Therapeutics Insider Trades Erasca Insider Trades Sana Biotechnology Insider Trades Upstream Bio Insider Trades Phathom Pharmaceuticals Insider Trades ORIC Pharmaceuticals Insider Trades Stoke Therapeutics Insider Trades Tourmaline Bio Insider Trades Eton Pharmaceuticals Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Beware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1 This page (NASDAQ:OPTN) was last updated on 4/16/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptiNose, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OptiNose With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OPTN Stock Free OPTN Stock Alerts